Arvaya Healthcare Limited has approved the acquisition of 100% equity shares of Sushodha Institute of Gastroenterology Private Limited for a total purchase consideration of ₹15,48,74,160. The acquisition, approved during its board meeting on July 11, 2026, will be discharged through the issuance of 38,71,854 fully paid-up equity shares at a price of ₹40 per share, including a premium of ₹30 per share. This strategic move aims to expand the company's footprint in specialized healthcare services and enhance revenue streams through integrated offerings.

The board also approved the fund raising by way of a Rights Issue of specified securities to eligible equity shareholders for a maximum amount not exceeding ₹210 Crores. A Rights Issue Committee comprising Mr. Kaushal Uttam Shah as Chairman, Mr. Salil Shetty, and Mr. Rahul Ravindra Mayur as members has been constituted to determine the terms and conditions of the issue. Additionally, the board approved the preferential allotment of equity shares to the shareholders of Sushodha Institute of Gastroenterology Private Limited for consideration other than cash.

The transaction involves related parties, including Mr. Bidari Kotresh Anilkumar and Mr. Dhanaji Dattatray Jadhav, who are shareholders of both the target entity and the company. The acquisition is based on a valuation report by Mr. Shreyas Bharat Ohara, a Registered Valuer, and is subject to shareholder approval. The target entity reported a turnover of ₹8.99 crore for the year 2025-26.

In other decisions, the board approved the appointment of Mr. Kaushal Shah and Mr. Ranganath Abhiram as Non-Executive Directors of SMCV Management Services Private Limited. The company also approved changing its registered office from Assam to Maharashtra. The postal ballot process was approved, with Mr. Chinmay Mohan Lele appointed as the Scrutinizer. The cut-off date for e-voting is July 10, 2026, and the e-voting period runs from July 15, 2026, to August 13, 2026.

Source: https://lodr-files.dhan.co/lodr-inputs/Company/INE491D01017/1a08ac2b-929c-407a-ba5b-0f51a0092942.pdf

Bijoy Hans Ltd will change its name to Arvaya Healthcare Limited effective July 13, 2026. BSE Limited has approved the application and recorded the new name, along with the Scrip ID ARVAYA for the BOLT Plus system. The change follows a prior disclosure submitted to the exchange on May 12, 2026.

The exchange issued a notice confirming the alteration in the company's identity and trading identifiers. The abbreviated name on the BOLT Plus System will also be updated to ARVAYA. This modification impacts the company's listing records and trading parameters on the exchange.

Change in Trading Details

The following table outlines the specific changes to the company's scrip details:

The approval was communicated by Marian Dsouza, Assistant Vice President - Listing Compliance & Operations at BSE Limited. The company's Managing Director, Kaushal Shah, signed the disclosure confirming the effective date of the name change.